TLR4 and AIDS: Collectively, we propose that the strategy of DC targeting via TLR4 or perhaps other receptors in the context of DNA vaccination will significantly enhance efficacy and may be particularly valuable for protection against chronic infectious diseases and emerging infectious diseases such as AIDS and COVID-19.